Clinical Trials in Philadelphia

Showing 17161-17180 of 20,904 trials

Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes

NCT01886170

In this two-phase mixed methods study, the investigators will first use patient feedback from semi-structured interviews to explore the ways in which patients with diabetes understand their diabetes and assess their disease control. The investigators will also use these interviews to elicit patient feedback on promising alternative communication formats to the hemoglobin A1C (A1C). In the second phase of the study, the investigators will test new formats to communicate information regarding diabetes control to patients with poorly controlled diabetes. This phase will be a three arm RCT comparing the effect of A1C (standard medical information) versus two alternative formats on several participant outcomes, primarily glycemic control at 6 months post-intervention.

Diabetes

University of Pennsylvania200 participantsStarted Oct 2013

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

NCT01592045

The purpose of this study is to compare the pharmacokinetics (blood levels) and safety of chimeric (ch) 14.18 manufactured by two independent drug makers (United Therapeutics \[UTC\] or the National Cancer Institute \[NCI\]).

Neuroblastoma

United Therapeutics28 participantsStarted Aug 2012

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +10 more locations

Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes

ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

Find Trials by Condition in Philadelphia

Transcutaneous Bilirubinometry in Neonates With Bilicare System

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia

BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy

Weight Watchers Online

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Induction-maintenance of Lopinavir/r in HIV-infected Subjects